Mr. Weaver, on Apoplexia Hydrocephalica

por Weaver, W.
Publicado 1806

On the Use of Arsenic in Eruption

por Weaver, W.
Publicado 1808

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

por Karaa, Amel, Haas, Richard, Goldstein, Amy, Vockley, Jerry, Weaver, W. Douglas, Cohen, Bruce H.
Publicado 2018

Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction

por Turer, Aslan T, Mahaffey, Kenneth W, Gallup, Dianne, Weaver, W Douglas, Christenson, Robert H, Every, Nathan R, Ohman, E Magnus
Publicado 2005

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque...

por Held, Claes, White, Harvey D., Stewart, Ralph A. H., Budaj, Andrzej, Cannon, Christopher P., Hochman, Judith S., Koenig, Wolfgang, Siegbahn, Agneta, Steg, Philippe Gabriel, Soffer, Joseph, Weaver, W. Douglas, Östlund, Ollie, Wallentin, Lars
Publicado 2017

Interleukin‐18 in patients with acute coronary syndromes

por Åkerblom, Axel, James, Stefan K., Lakic, Tatevik G., Becker, Richard C., Cannon, Christopher P., Steg, Philippe G., Himmelmann, Anders, Katus, Hugo A., Storey, Robert F., Wallentin, Lars, Weaver, W. Douglas, Siegbahn, Agneta
Publicado 2019

Availability of Services and Caregiver Burden: Supporting Individuals With Neurogenetic Conditions During the COVID-19 Pandemic

por Kowanda, Michelle, Cartner, Lindsey, Kentros, Catherine, Geltzeiler, Alexa R., Singer, Kaitlyn E., Weaver, W. Curtis, Lehman, Christopher D., Smith, Simone, Smith, Rebecca Sheedy, Walsh, Lauren Kasparson, Diehl, Katharine, Nagpal, Natalie, Brooks, Elizabeth, Mebane, Caroline M., Wilson, Ashley L., Marvin, Alison R., White, L. Casey, Law, J. Kiely, Jensen, William, Daniels, Amy M., Tjernagel, Jennifer, Snyder, LeeAnne Green, Taylor, Cora M., Chung, Wendy K.
Publicado 2021

Lipoprotein‐Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

por Wallentin, Lars, Held, Claes, Armstrong, Paul W., Cannon, Christopher P., Davies, Richard Y., Granger, Christopher B., Hagström, Emil, Harrington, Robert A., Hochman, Judith S., Koenig, Wolfgang, Krug‐Gourley, Sue, Mohler, Emile R., Siegbahn, Agneta, Tarka, Elizabeth, Steg, Philippe Gabriel, Stewart, Ralph A. H., Weiss, Robert, Östlund, Ollie, White, Harvey D., Budaj, Andrzej, Ardissino, Diego, Avezum, Alvaro, Aylward, Philip E., Bryce, Alfonso, Chen, Hong, Chen, Ming‐Fong, Corbalan, Ramon, Dalby, Anthony J., Danchin, Nicolas, De Winter, Robbert J., Denchev, Stefan, Diaz, Rafael, Elisaf, Moses, Flather, Marcus D., Goudev, Assen R., Grinfeld, Liliana, Husted, Steen, Kim, Hyo‐Soo, Linhart, Ales, Lonn, Eva, López‐Sendón, José, Manolis, Athanasios J., Nicolau, José C., Pais, Prem, Parkhomenko, Alexander, Pedersen, Terje R., Pella, Daniel, Ramos‐Corrales, Marco A., Ruda, Mikhail, Sereg, Mátyás, Siddique, Saulat, Sinnaeve, Peter, Sritara, Piyamitr, Swart, Henk P., Sy, Rody G., Teramoto, Tamio, Tse, Hung‐Fat, Weaver, W. Douglas, Viigimaa, Margus, Vinereanu, Dragos, Zhu, Junren
Publicado 2016